Synchron building next-generation transcatheter high-channel whole-brain interface — San Diego engineering hub established
Summary
Alongside the $200M Series D announcement, Synchron revealed it is actively developing a next-generation BCI described by CEO Tom Oxley as a "transcatheter high-channel whole-brain interface" that will have "potentially more applications" than the current Stentrode. The company established a new San Diego engineering hub to build this advanced system, drawing on local talent from Dexcom, Qualcomm, and other San Diego medical technology and semiconductor companies. Synchron will also set up vertically integrated manufacturing operations in Southern California. The NYC office is growing an AI team specifically trained to decode thought in real time from brain data.
Why it matters
Synchron building a vertically integrated manufacturing operation in San Diego — alongside Dexcom's CGM manufacturing expertise and Qualcomm's wireless semiconductor talent — is exactly the right geographic strategy for a company developing an endovascular implant with wireless communication. Southern California's medical device manufacturing ecosystem is second only to Minneapolis in the US. The "whole-brain" framing of the next-gen system signals ambition to move from motor cortex communication BCI to multi-region neural interface.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial